Clinical Trial Update: Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and early efficacy of a Helicobacter pylori vaccine in adults who are H. pylori-negative; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Helicobacter pylori vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Helicobacter Pylori Infection | Phase 1 | Status: COMPLETED | Results posted: 2017-02-28